David M. Dobrzynski, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-0526

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 689
Rochester, NY 14642

Faculty Appointments

Assistant Professor - Department of Medicine , Infectious Diseases (SMD)

Patient Care Settings

Hospital Medicine, Infectious Diseases

Biography

Professional Background

Dr. Dobrzynski received his Bachelor of Science in Biochemistry from Bucknell University and his Doctorate of Medicine from Albany Medical College. He completed his Internal Medicine Residency at Wake Forest Baptist Medical Center(WFBMC) in Winston-Salem, NC. He continued on as faculty at WFBMC as an Assistant Chief of Medicine for the following year. He then went on to complete his Infectious Diseases Fellowship at Vanderbilt University in Nashville, TN.
He currently sees inpatients on the General Infectious Diseases consult service as well as outpatients in the general ID Clinic. He also serves as Program Director of the Infectious Diseases Fellowship Program and Medical Director for the Antimicrobial Stewardship Program at Strong Memorial Hospital.

Research

His main clinical research interests include respiratory viral infections, COVID-19 therapeutics, antimicrobial stewardship, multi-drug resistant organisms, and hospital-acquired infections. He also remains active in teaching of fellows, residents, and medical students.

Credentials

Education

2012
MD | Albany Medical College of Union University

Post-doctoral Training & Residency

07/01/2016 - 06/30/2018
Fellowship in Infectious Disease at Vanderbilt University Medical Center

06/24/2013 - 06/23/2015
Residency in Internal Medicine at Wake Forest University Baptist Medical Center-Radiology

06/24/2012 - 06/23/2013
Internship in Internal Medicine at Wake Forest University Baptist Medical Center-Radiology

VIEW ALL

Publications

Journal Articles

7/11/2023
Lyke KE, Atmar RL, Dominguez Islas C, Posavad CM, Deming ME, Branche AR, Johnston C, El Sahly HM, Edupuganti S, Mulligan MJ, Jackson LA, Rupp RE, Rostad CA, Coler RN, Bäcker M, Kottkamp AC, Babu TM, Dobrzynski D, Martin JM, Brady RC, Frenck RW, Rajakumar K, Kotloff K, Rouphael N, Szydlo D, PaulChoudhury R, Archer JI, Crandon S, Ingersoll B, Eaton A, Brown ER, McElrath MJ, Neuzil KM, Stephens DS, Post DJ, Lin BC, Serebryannyy L, Beigel JH, Montefiori DC, Roberts PC, . "Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants." NPJ vaccines.. 2023 Jul 11; 8(1):98. Epub 2023 Jul 11.

7/2023
Ince D, Fiawoo S, Choudhury R, Cosgrove SE, Dobrzynski D, Gold H, Lee JH, Percival KM, Shulder S, Sony D, Spivak ES, Tamma PD, Nori P. "Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals." Open forum infectious diseases.. 2023 Jul; 10(7):ofad265. Epub 2023 May 22.

10/21/2022
Debnath A, Pillinger KE, Martin AJ, Dobrzynski D, Cameron A, Shulder S. "Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections." The Annals of pharmacotherapy.. 2022 Oct 21; :10600280221132019. Epub 2022 Oct 21.

VIEW ALL PUBLICATIONS